The mixed results showed that ivonescimab plus chemotherapy reduced the risk of disease progression or death by 48% compared to chemotherapy alone. Summit Therapeutics announced its intention to file ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

MAIA Biotechnology, Inc. ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced updated data from its THIO-101 ...

Generative AI can support decisions about a clinical trial’s target patient population by enhancing subgroup discovery, refining trial eligibility criteria, and helping remove patients who are ...

Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

After years of little innovation, a number of new treatments are entering Phase II and III schizophrenia clinical research. As the demand for trial sites increases, this means that less experienced ...

Medidata Protocol Optimization, a flagship component of the unified Study Experience, transforms trial design and execution by leveraging AI-driven predictive modeling, digital pr ...

Today’s Forbes Daily newsletter covers higher steel and aluminum tariffs, Americans sour on Elon Musk, Meta's nuclear deal, ...

Professor Chak-sing Lau, Vice-President & Pro-Vice-Chancellor (Health) and Dean of Medicine at the University of Hong Kong (HKU), led a pivotal session titled 'Unlocking the Potential of AI in ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.